Glaxo to Pay $750 Million in Adulterated Drugs Case
October 27th, 2010Via: Reuters:
GlaxoSmithKline Plc has agreed to pay $750 million and plead guilty to manufacturing and distributing adulterated drugs from a now closed plant in Puerto Rico, the U.S. Justice Department said on Tuesday.